Health Benefits of Lowering Sodium Intake in the US

Similar documents
The Evidence for Populationwide Reduction in Sodium Intake: Why All the Fuss?

Sodium and Health: Evidence, Policy, Reality

Disclaimer for sharing or use of any of this presentation

The Need for Balance in Evaluating the Evidence on Na and CVD

HYPERTENSION GUIDELINES WHERE ARE WE IN 2014

Why you should take the latest sodium study with a huge grain of salt

Salt reduction - benefits beyond blood pressure

What s In the New Hypertension Guidelines?

Sodium and Potassium Intake and Cardiovascular and Bone Health:

MANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION

Hypertension Management Controversies in the Elderly Patient

Update in Hypertension

Hypertension in 2015: SPRINT-ing ahead of JNC-8. MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE

HYPERTENSION: UPDATE 2018

Difficult-to-Control & Resistant Hypertension. Anthony Viera, MD, MPH, FAHA Professor and Chair

ADVANCES IN MANAGEMENT OF HYPERTENSION

Objectives. Describe results and implications of recent landmark hypertension trials

Hypertension and the SPRINT Trial: Is Lower Better

IS IT TIME TO REDUCE SALT IN SOUTH AFRICAN FOOD? KRISELA STEYN DEPT OF MEDICINE, UCT CHRONIC DISEASES INITIATIVE IN AFRICA

Interventions to reduce progression of CKD what is the evidence? John Feehally

Risk Factors for Heart Disease

Placebo-Controlled Statin Trials EXPLAINING THE DECREASE IN DEATHS FROM CHD! PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN EXPLAINING THE DECREASE IN

Using the New Hypertension Guidelines

Cardiovascular Disease Prevention: Current Knowledge, Future Directions

NUTRITION IN THE AGE OF EVIDENCE D A N A H. M A N N I N G P H A R M. D., R. D., L D N

In almost every country that has established guidelines for

Hypertension Update Clinical Controversies Regarding Age and Race

Diabetes Mellitus: A Cardiovascular Disease

Vascular Diseases. Overview: Selected Slides

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids.

ADVANCES IN MANAGEMENT OF HYPERTENSION

The earlier BP control the better cardiovascular outcome. Jin Oh Na Cardiovascular center Korea University Medical College

Treating Hypertension in 2018: What Makes the Most Sense Today?

Modern Management of Hypertension

JNC 8 -Controversies. Sagren Naidoo Nephrologist CMJAH

Placebo-Controlled Statin Trials Prevention Of CVD in Women"

Blood Pressure Measurement in SPRINT

Managing Hypertension in 2018

New Recommendations for the Treatment of Hypertension: From Population Salt Reduction to Personalized Treatment Targets

Should we base treatment decisions on short-term or lifetime CVD risk? Rod Jackson University of Auckland New Zealand

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University

Hypertension targets: sorting out the confusion. Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town

T. Suithichaiyakul Cardiomed Chula

DISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials

Mesures non médicamenteuses pour prévenir et traiter une hypertension artérielle. JM Krzesinski Service de Néphrologie- Hypertension ULg-CHU Liège

Blood pressure and urinary sodium in men and women: the Norfolk Cohort of the European Prospective Investigation into Cancer (EPIC-Norfolk) 1 3

New Hypertension Guidelines: Why the change? Neil Brummond, M.D. Avera Medical Group Internal Medicine Sioux Falls, SD

Project Summary: Draft Proposal Continued RESULTS. on the DASH Diet and 30 of the 40 original subjects on the Pro-DASH Diet.

Socioeconomic status and the 25x25 risk factors as determinants of premature mortality: a multicohort study of 1.7 million men and women

Management of Hypertension in Women

Blood Pressure LIMBO How Low To Go?

Systolic Blood Pressure Intervention Trial (SPRINT)

Fructose, Uric Acid and Hypertension in Children and Adolescents

Recent Hypertension Guidelines

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.

Placebo-Controlled Statin Trials MANAGEMENT OF HIGH BLOOD CHOLESTEROL MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:

Primary Physiological

Antihypertensive Trial Design ALLHAT

The Metabolic Syndrome: Is It A Valid Concept? YES

No relevant financial relationships

Disclosures. Overview 9/30/ ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

Egyptian Hypertension Guidelines

Management of Lipid Disorders and Hypertension: Implications of the New Guidelines

The prevalence of hypertension in a representative

Current CDC Efforts Concerning Sodium Intake

Preventing and Treating High Blood Pressure

UPDATES IN AMBULATORY MEDICINE ERIK RIESSEN, MD, FACP INTERMOUNTAIN MEDICAL CENTER OUTPATIENT INTERNAL MEDICINE RESIDENCY CLINIC

Modern Management of Hypertension: Where Do We Draw the Line?

Optimizing Postpartum Maternal Health to Prevent Chronic Diseases

Jared Moore, MD, FACP

Hypertension in the Elderly. John Puxty Division of Geriatrics Center for Studies in Aging and Health, Providence Care

Blood Pressure Acre Surgery Diviash Thakrar

Director of the Israeli Institute for Quality in Medicine Israeli Medical Association July 1st, 2016

Diversity and HTN: Approaches to optimal BP control in AfricanAmericans

Economically efficient approaches to address chronic disease in developing countries

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension

Role of Minerals in Hypertension

w High Blood Pressure Guidelines Create New At-Risk Classification

40% minimum reduction from

Salt: How much less should we eat for health? Understanding the recent IOM report

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Prevenzione cardiovascolare e cambiamento degli stili di vita. Gian Franco Gensini

Hypertension JNC 8 (2014)

Marginal donors: Young vs. Old

Causes of Poor BP control Rates

2009 Shattuck Lecture

Hypertension Management: A Moving Target

Adolescent Hypertension Roles of obesity and hyperuricemia. Daniel Landau, MD Pediatrics, Soroka University Medical Center

Lessons learned from AASK (African-American Study of Kidney Disease and Hypertension)

What is hypertension?

Συμπεράσματα από τις νέες μελέτες για την αρτηριακή υπέρταση (SPRINT,PATHAY 2,HOPE 3)

The effect of a change in ambient temperature on blood pressure in normotensives

Diabetes and Hypertension

Understanding new international guidelines to tackle CV Risk: A practical model John Deanfield, MD UCL, London United Kingdom s

Changing the Food Environment to Reduce Cardiovascular Disease Risk

Managing HTN in the Elderly: How Low to Go

10/8/2015. MN Nursing Conference October 7th, 2015 Michael Miedema, MD MPH. None

Transcription:

Health Benefits of Lowering Sodium Intake in the US Lawrence J Appel, MD, MPH Professor of Medicine, Epidemiology and International Health (Human Nutrition) Director, Welch Center for Prevention, Epidemiology and Clinical Research The Johns Hopkins University Dec 5, 2012

Research Disclosure McCormick Foundation

Outline Benefits of Lowering Sodium Intake Methodological Challenges Measurement of blood pressure Measurement of sodium Intake Cohort studies

Worldwide, Elevated BP is the Leading Cause of Preventable Deaths Global health risks: http://www.who.int/healthinfo/global_burden_disease, WHO, 12/09

Critical Facts: (1) Magnitude of the BP Epidemic 54% of strokes and 47% of coronary heart disease events attributed to elevated BP 1 26% of adults worldwide (971 million) have hypertension 2 Lifetime risk 3 of developing hypertension is 90% 1 Lawes CM Lancet 2008;371:1513 2 Kearney Lancet 2005;305:217 3 Vasan JAMA 2002; 287:1003

mm Hg Mean Systolic BP Rises with Age (U.S. Women) 150 140 130 120 110 100 90 80 70 SBP Rise with Age = ~0.6 mmhg per year Black White Mexican-American 18-29 30-39 40-49 50-59 60-69 70-79 80+ Burt, Hypertension 1995;26:60. Age

Critical Facts: (2) Costs of the BP Epidemic Projected direct (medical) costs of CVD in 2030 in billions All CVD $818b Hypertension $200b CHD $106b Heart Failure $77b Stroke $95b [Hypertension as risk factor] $389b Heidenreich PA.Circulation. 2011;123:933-44

Types of Evidence Linking Sodium Intake to Blood Pressure Epidemiology Migration Genetic Animal Trials Population Interventions Over 50 population studies Several, e.g. Kenya All defects identified so far impair the ability of the kidney to excrete salt. All forms of hypertension are caused or aggravated by salt No study has documented increased CVD risk from reduced sodium Children: ~10 trials, one trial in infants Adults: > 50 trials, 10 dose-response Northern Japan Finland Portuguese villages

As Sodium Intake Is Reduced, So is Blood Pressure Typical Diet Systolic Blood Pressure 8.9 mmhg from low Na +DASH -6.7 p<.0001-3.0 P<.0001 DASH Diet 1,500 2,400 3,300 Sodium Level: mg/d per day Sacks, NEJM 2001;344:3

Factors Associated with Greater BP Reduction from Lower Sodium Intake Fixed factors African-Americans Middle and older-aged persons Genetic Factors Individuals with: Hypertension Diabetes Chronic Renal Insufficiency Modifiable Low potassium intake Poor quality diet

Recommended Upper Limits Upper Limits for: General High Risk* % of US Adults 52% 48%** Sodium (mg) 2,300 1,500 Sodium (mmol) 100 65 Salt (g), [Sodium Chloride] 5.8 3.8 *African-Americans, Adults > 51 yrs, Hypertensives, and Diabetics **MMWR 2011, Vol 60, No. 41

Reduced Sodium Intake Has Greater BP Effects in African-Americans African-Americans Non-African-Americans 0 P-interaction < 0.05 Vollmer, Ann Int Med 2001;135:1019

Reduced Sodium Intake Has Greater BP Effects in Hypertensives Hypertensives Non-Hypertensives 0 P-interaction < 0.05 Vollmer, Ann Int Med 2001;135:1019

Dose Response Trial in Hypertensives SBP (mm Hg) DBP (mm Hg) 200 180 160 140 120 100 80 60 40 +8* +8* +4* +5* 1.1 (50) 2.3 (100) 4.6 (200) grams/day (mmol/day) MacGregor, 1989 (20 hypertensive)

Reduced Sodium Intake Has Greater BP Effects in Middle- and Older-Aged Persons than Younger Persons Age > 45 Age < 45-3.9-5.3-2.8 * - 7.5 P-interaction < 0.05 Vollmer, Ann Int Med 2001;135:1019

Dose Response in Elderly with Isolated Systolic Hypertension SBP (mmhg) DBP (mmhg) 200 180 160 140 120 100 80 60 40 +9.0 +1.8 +4.1 +6.0 +3.1 +0.3 +3.4-0.3 0.001 P <0.01* 0.01 P <0.05* 0.92 (40) 2.1(90) 3.2(140) 5.5 (240) 7.8 (340) grams/day (mmol/day) Johnson, 2001 (n=15 elderly with isolated systolic hypertension)

Trials of Sodium Reduction in Patients with Diabetes 13 trials with 254 individuals 75 individuals with type 1 diabetes 158 individuals with type 2 diabetes Duration median: 1 week, range: 5 days to 12 wks * Suckling RJ, Cochrane Review, 2010 Dec 8;(12):CD006763

BP Reductions from Lowering Sodium Intake: Diabetes Type 1 DM Type 2 DM SBP (mmhg) -7.1-6.9 DBP (mmhg) -3.1-2.9 Median Na (mg/d) Reduction 4,700 2,900 * Suckling RJ, Cochrane Review, 2010 Dec 8;(12):CD006763

Estimated BP Reductions from Lowering Sodium Intake SBP (mmhg) DBP (mmhg) Na (mg/d) Reduction Children 1 Non-HTN 2 HTN 2 HTN 3 Resistant -1.2-2.0-5.0-22.7-1.3-1.0-2.7-9.1 n/a 1,700 1,800 2,300 1 He,HTN 2006;48:861 2 Cochrane Review, 2006; 3 Pimenta, HTN 2009;54:475

Population-Based Strategy SBP Distributions After Intervention Before Intervention Reduction in BP Stamler R. Hypertension 1991;17:I-16 I-20. Reduction in SBP mmhg 2 3 5 % Reduction in Mortality Stroke CHD Total -6-4 -3-8 -5-4 -14-9 -7

Estimated Annual Number of Prevented Heart Attacks from Population-Wide Sodium Reduction Bibbins-Domingo, NEJM 2010;362:590

Estimated Annual Number of Prevented Heart Attacks from Population-Wide Sodium Reduction Bibbins-Domingo, NEJM 2010;362:590

Sodium Reduction Lowers CVD Risk: Meta-Analysis of Trials Events Na/Cntl Trial TOHP I 17 / 32 TOHP II 71 / 80 Morgan 6 / 5 TONE 36 / 46 Total 130 / 163 He FJ, MacGregor GA. Lancet. 2011;378:380 382

Methodological Issues

Blood Pressure: High Degree of Random Error (Noise) Huge within-person variability in blood pressure Reduced by: Standardized technique Multiple visits Multiple measurements (e.g. ambulatory BP) Implication: Impossible to classify individuals as salt sensitive

Distribution of Systolic BP Change in Non- Hypertensive Adults (Pre-Post) in Response to Reduced Sodium Intake Miller, J Chronic Dis 40, 1987

Percent of Participants Distribution of Systolic BP Differences Between Two Periods When Participants Ate the Same Diet/Same Sodium 35 30 25 20 15 10 5 0-30 -25-20 -15-10 -5 0 5 10 15 20 25 Obarzanek, HTN 2003;42:459 SBP Change (mmhg)

Percent of Participants Distribution of Systolic BP Differences Between Two Periods with Different Sodium 35 Levels (~ 70 mmol/d) 30 25 20 15 10 5 0-30 -25-20 -15-10 -5 0 5 10 15 20 25 SBP Change (mmhg) Obarzanek, HTN 2003;42:459

Major Methodological Challenges in Observational Studies that Relate Sodium Intake to CVD Random error in sodium assessment Systematic error in sodium assessment Potential for reverse causality Major analytic issue, e.g. under-adjustment Potential for residual confounding 26 studies with 31 independent samples On average, 2.5 issues/study

Random and Systematic Error in Measuring Na Intake Random error Reason: high day-to-day variability of Na within an individual Impact: bias to the null Systematic error Reason: underreporting of intake from 24 hr recalls OR incomplete urine collection Impact: potential for paradoxical relationship Both types of errors extremely common

Measurement of Na Intake Optimal Multiple, high quality 24 hour urine collections Suboptimal 24 hour urine collected with limited or no attention to quality control Spot, overnight or timed urines 24 hour dietary recalls Food frequency questionnaire

Correlations of Sodium with Indices of Completeness Diet Studies: Correlation of sodium and calorie 0.80 in NHANES 1 0.73 in PREMIER 2 trial Urine Studies: Correlations of Sodium with creatinine excretion 0.56 in PREMIER 2 trial 1 Dietary Guidelines Scientific Advisory Committee, 2010 2 Unpublished

CVD Risk Random Error in Na Measurement Attenuates the Relationship of Na Intake on CVD Risk Sodium Intake Actual Impact of Random Error

CVD Risk Random Error in Na Measurement Attenuates the Relationship of Na Intake on CVD Risk Sodium Intake Actual Impact of Random Error

CVD Risk Systematic Error in Na Measurement Attenuates the Relationship of Na Intake on CVD Risk Sodium Intake Actual Impact of Systematic Error

CVD Risk Systematic Error in Na Measurement Could Lead to J-Shaped or Inverse Relationship of Na Intake with CVD Risk Sodium Intake Actual Potential Impact of Systematic Error

Observational Study with Systematic Error in Na Assessment: NHANES II

Hazard Ratio (HR) Case of Systematic Error Leading to Bias: Increased CVD Mortality in Persons with Lowest Na (by Quartile of Na Intake in mg/d) 3 2 1.8 1.94 1.48 P=0.03 Q1 vs Q4 1 1 0 1 Cohen, JGIM 2008;23:1297-302 1st 2nd 3rd 4th Na Quartile of based on mg of Na/d

Evidence of Contamination in a Cohort Study 1 (NHANESIII) Reporting Increased Mortality in Persons with Low Sodium Intake on 24Hr Dietary Recall Quartile of Sodium Intake: 1 st (Lowest) 2nd 3rd 4 th (Highest) Na (mg/d) 1,501 2,483 3,441 5,497 1 Cohen, JGIM 2008;23:1297-302

Evidence of Contamination in a Cohort Study 1 (NHANESIII) Reporting Increased Mortality in Persons with Low Sodium Intake on 24Hr Dietary Recall Quartile of Sodium Intake: 1 st (Lowest) 2nd 3rd 4 th (Highest) Na (mg/d) 1,501 2,483 3,441 5,497 Energy Intake (kcal) 1,282 1,762 2,152 2,938 1 Cohen, JGIM 2008;23:1297-302

Evidence of Contamination Evidence in a Cohort of Massive Study 1 (NHANESIII) Reporting Underreporting Increased Mortality of Calorie in Persons Intake with Low Sodium Intake Leading on 24Hr to Systematic Dietary Recall Error in Estimate or Sodium Intake Quartile of Sodium Intake: 1 st (Lowest) 2nd 3rd 4 th (Highest) Na (mg/d) 1,501 2,483 3,441 5,497 Energy Intake (kcal) 1,282 1,762 2,152 2,938 BMI (kg/m 2 ) 25.8 26.4 26.3 26.6 1 Cohen, JGIM 2008;23:1297-302

Hazard Ratio (HR) Reduced Systematic Error from Use of Na/Kcal Ratio as Exposure instead of Na/d 2 1 1.25 0.9 0.9 P=0.26 Q1 vs Q4 1 0 1 Cohen, JGIM 2008;23:1297-302 1st 2nd 3rd 4th Na Quartile of based on mg of Na /Kcal

J-Shaped Relationship of Total Mortality with Urine Sodium Excretion in Patients with Type 1 Diabetes Extremely low levels are most likely the result of extreme undercollection Thomas, Diabetes Care 2011: 861-6

Example of Low Sodium Excretion Related to Under-collection 78 year old women, screened for a trial No special diet 172 pounds, 5 2, BMI 31 kg/m 2 Two 24 hour urine collections required Detailed instructions provided Urine Lab Range 1st 2nd Sodium (mmol/24hr) 18 21 Volume (ml/24hr) 800 725 Creatinine (g/24 hr).63 to 2.5.41.09

Arguments Made by Those who Oppose Sodium Reduction Clinical trial of sodium reduction with hard clinical outcomes is needed Only salt sensitive persons should reduce their salt intake Such trials are impossible because of logistical, financial and ethical considerations. No test available. Irrelevant given the massive scope of the blood pressure epidemic. Extremely unlikely: 1) major methodological limitations of cohort studies + 2) overinterpretation of biomarkers Sodium reduction might be harmful

Trials of Sodium Reduction in Participants Heart Failure by Paterna Hospitalized NYHA Class III Heart Failure Intensive medication regimens 100% ACEI 100% Lasix 85% Spironolactone Medical management Unconventional, leading to untreated longterm volume depletion Paterna, Am J Card 2009:103:93 Paterna, Am J Med Science 2011, 342: 27

No Effect of Reducing Sodium Intake on LDL Cholesterol Typical Diet LDL-C mmol/l +0.04 P=0.3 0.0 P=0.9 DASH Diet Harsha, Hypertension 2004;43;393 1,500 2,400 3,300 Sodium Level: mg/d per day

Key Points to Remember The estimated benefits of sodium reduction are substantial and warrant major public health efforts to reduce salt intake Major methodological issues limit the usefulness of available cohort studies as a basis for guiding policy, much less reversing recommendations